There are 3,458 papers on bone mineral density in aging research: 276 trials and 1,941 observational studies in people, 352 in animals, 3 in cells, 755 reviews. The newest story, Nov 17, 2026: “Loneliness linked to poorer bone health in older men”.
Older age is linked with lower bone mineral density in human observational studies. Human trials report increases with denosumab in osteoporosis and etidronic acid in postmenopausal women; exercise results vary, with gains after resistance training but no clear effect after eight weeks of aerobic dance in women or three months of whole-body vibration in women.
1,541 findings in 1,159 papers from 1992 to 2026, 238 of them since April 2026
“total hip BMD was the strongest modifiable predictor of all clinical fractures (per 1 SD = 0.1 g/cm2 increase, HR 0.47; 95% CI, 0.39-0.58).”
Exercise was not clearly linked with bone mineral density in humans.
“There were no differences in total or regional lean mass, bone mineral density, trabecular bone score, or fracture risk assessment tool between groups.”
Exercise was not clearly linked with bone mineral density in humans (controlling lean mass, years PM, and past exercise) (p=0.97).
“There were no significant differences in total BMD (p=0.97), TBS (p=0.23) hip FRAX (p=0.66), or major osteoporotic FRAX (p=0.53) between the women who were sedentary, runners, swimmers and HIT.”
Humanscontrolling lean mass, years PM, and past exercisefemalesn = 58
Exercise improves bone mineral density in humans (post-stroke osteoporosis).
“Comprehensive exercise combining aerobic exercise with muscle strengthening and skeletal loading (e.g., FAME program) could maintain the bone mineral density (BMD) of the femoral neck on the affected side”
Reviewpost-stroke osteoporosisfemoral neck on the affected side
Resistance training increases bone mineral density in humans.
“At week 24, compared to the CG, the RG, YG, and BG exhibited significantly higher BMD at lumbar L2–4 (p = 0.049, p = 0.016, p = 0.040) and higher PINP levels (p = 0.026, p = 0.029, p = 0.020), and lower β-CTX levels (p = 0.001, p = 0.012, p = 0.042).”
Resistance training increases bone mineral density in humans (peri-menopausal women).
“progressive resistance training, particularly at moderate-to-high intensities (≥ 70–85% of one-repetition maximum), significantly increases BMD in the lumbar spine and femoral neck.”
Reviewperi-menopausal womenmoderate-to-high intensitieslumbar spine≥ 70–85% of one-repetition maximumfemales
Resistance training increases bone mineral density in humans (osteoporosis).
“The combination of different methods, including power, circuits, drop set, superset and isometrics resulted in effectiveness in reducing severity and improving BMD.”
Reviewosteoporosisdrop set, superset and isometryboneHigh intensity; 2 to 3 sessions/week, 2 to 5 sets per exercise, 5 to 10 repetitions20 to 52 weeks
International Journal of Research in Medical Sciences·
Hormone replacement therapy increases bone mineral density in humans (compared with exercise therapy alone) (greater improvements than exercise therapy alone; no numbers given).
“there were greater improvements in BMD than exercise therapy alone”
Reviewcompared with exercise therapy alonebonefemales
GLP-1 receptor agonists showed no clear effect on bone mineral density in humans (meta-analytical models including the most adjusted effect size).
“No effect on bone outcomes (i.e., bone mineral density [all sites] and fractures [all sites]) were observed when the meta-analytical models included the most adjusted effect size.”
Human trialmeta-analytical models including the most adjusted effect sizebone
GLP-1 receptor agonists decrease bone mineral density in humans (people living with obesity) (slight reduction).
“Although initial findings suggest that GLP-1Ra leads to a slight reduction in bone mineral density and promotes bone remodeling, favoring resorption similar to calorie restriction effects”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Denosumab improves bone mineral density in Chinese osteoporosis patients (p = 0.005).
“One-year outcome data analysis revealed that the denosumab group showed significantly greater improvements than the control group in bone mineral density (p = 0.005), dominant hand grip strength (p = 0.014), 6-m walk gait speed (p = 0.012), and 5 times sit-up time (p = 0.021).”
Human trialin Chinese osteoporosis patients12-month
Denosumab increases bone mineral density in humans (postmenopausal osteoporosis at high fracture risk) (+9.6% lumbar spine, +7.3% femoral neck, pall < 0.05).
“Denosumab administration (treatment duration 43 months), lead to BMD improvement by + 9.6% at the lumbar spine and + 7.3% at the femoral neck (pall < 0.05).”
Human trialpostmenopausal osteoporosis at high fracture risksubcutaneous injection60 mg subcutaneously every 6 months43 monthsfemalesn = 130
Denosumab increases bone mineral density in osteoporosis.
“Denosumab, a targeted anti-osteoporotic agent, mediates therapeutic effects by inhibiting bone resorption through the RANK-RANKL-OPG (RRO) pathway, consequently enhancing bone mineral density.”
Physical activity is linked with higher bone mineral density in humans (compared with the inactive group) (β = 0.021, 95% CI 0.008-0.035, P = 0.004).
“In NHANES, both the WW pattern and the regular active (RA) pattern were associated with higher femoral neck BMD compared with the inactive group (WW: β = 0.021, 95% CI 0.008-0.035, P = 0.004”
Physical activity was not clearly linked with bone mineral density in humans (mobility limitations) (1.084 ± 0.012 vs 1.076 ± 0.011 g/cm2, p = .99).
“No significant difference in BMD was found between participants meeting physical activity guidelines (1.084 ± 0.012 g/cm2) and those who did not meet guidelines (1.076 ± 0.011 g/cm2; p = .99).”
Physical activity increases bone mineral density in humans.
“regular PA, including moderate-to-vigorous intensity weight-bearing PA and resistance training activities, is consistently linked to greater BMD and reduced fracture risk.”
Caloric restriction decreases bone mineral density in humans.
“Intentional weight loss through caloric restriction or bariatric surgery consistently accelerates bone turnover and reduces bone mineral density (BMD)”
Bariatric surgery decreases bone mineral density in humans.
“Intentional weight loss through caloric restriction or bariatric surgery consistently accelerates bone turnover and reduces bone mineral density (BMD)”
Bariatric surgery decreases bone mineral density in humans (obesity).
“bariatric surgery exerts multiple adverse effects on bone tissue, characterized by significantly increased bone resorption, decreased bone mineral density (BMD)”
Combined aerobic and resistance training increases bone mineral density in humans (compared with single-modality training).
“Combined programs (e.g., resistance plus aerobic/weight-bearing components) produced relatively greater improvements in BMD and functional outcomes than single-modality training.”
Reviewcompared with single-modality trainingresistance plus aerobic/weight-bearing components
Diabetes, metabolic syndrome and obesity : targets and therapy·
Dapagliflozin decreases bone mineral density in humans (type 2 diabetes mellitus) (0.00 ± 0.02 vs -0.02 ± 0.04 g/cm2, p = 0.0402).
“Femoral neck BMD decreased significantly in the dapagliflozin group compared with the evogliptin group, although the absolute between-group difference was small (0.00 ± 0.02 vs -0.02 ± 0.04 g/cm2, p = 0.0402).”
Human trialtype 2 diabetes mellitusfemoral neck48 weeksfemalesn = 60
Diabetes, metabolic syndrome and obesity : targets and therapy·
Dapagliflozin decreases bone mineral density in postmenopausal women with T2DM (-0.02 ± 0.04 (p = 0.0275)).
“femoral neck, the Evogliptin group showed a change of 0.00 ± 0.02 (p = 0.9620) versus -0.02 ± 0.04 (p = 0.0275) in the Dapagliflozin group, yielding a significant intergroup difference (p = 0.0402).”
Human trialin postmenopausal women with T2DM48 weeksfemales
Acupuncture showed no clear effect on bone mineral density in humans (Patients with osteoporosis; comparison with the supplementation-only control group).
“was significantly higher than that before treatment, but there was no statistical difference with the control group.”
Human trialPatients with osteoporosis; comparison with the supplementation-only control groupFemoral neck and hip6 monthsn = 226
Whole-body vibration showed no clear effect on bone mineral density in humans.
“There was no statistically significant difference in terms of L2-L4 vertebrae, femoral neck, and total femur BMD, OC, and hydroxyproline values in all three groups after treatment compared to the baseline (p>0.05; Tables 2, 3).”
Yijinjing increases bone mineral density in humans.
“At week 24, compared to the CG, the RG, YG, and BG exhibited significantly higher BMD at lumbar L2–4 (p = 0.049, p = 0.016, p = 0.040) and higher PINP levels (p = 0.026, p = 0.029, p = 0.020), and lower β-CTX levels (p = 0.001, p = 0.012, p = 0.042).”
Yijinjing increases bone mineral density in humans (versus control) (MD = 0.11, 95% CI 0.00 to 0.16).
“Yijinjing (MD = 0.11, 95% CI 0.00 to 0.16; SUCRA = 71.3%), and Taiji (MD = 0.07, 95% CI0.04 to 0.09; SUCRA = 57.4%) were significantly more effective than control.”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Age decreases bone mineral density in humans (multiple linear regression analysis) (β = −0.25, P = 0.001).
“Multiple linear regression analysis results showed that age was negatively correlated with the degree of BMD improvement (β = −0.25, P = 0.001), meaning that the older the age, the smaller the degree of BMD improvement.”
Human trialmultiple linear regression analysis6-monthfemalesn = 70
Age is linked with lower bone mineral density in humans.
“Both BMD and yield strength declined with advancing age, with significantly steeper reductions observed in females and in individuals with lower BMI.”
QJM : monthly journal of the Association of Physicians·
Type 2 diabetes
↔no changein humans4↑upin humans1
5 studies
Type 2 diabetes was not clearly linked with bone mineral density in humans (Comparable improvements in both groups).
“Both groups showed comparable bone mineral density improvements.”
HumansComparison of postmenopausal women with osteoporosis with versus without type 2 diabetes mellitus, all receiving annual zoledronate, calcium, cholecalciferol, and fall-prevention measures5 yearsfemalesn = 150
Type 2 diabetes is linked with higher bone mineral density in humans (total hip, 4.4% higher; femoral neck (FN), 4.9% higher; and lumbar spine, 5.2% higher).
“Women with T2D had higher bone mineral density (BMD) at all sites (total hip, 4.4% higher; femoral neck (FN), 4.9% higher; and lumbar spine, 5.2% higher)”
“Traditionally, obesity has been viewed as protective against osteoporosis, given that a higher body mass index (BMI) is linked to increased bone mineral density (BMD).”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Body weight is linked with higher bone mineral density in humans (dysglycemia) (p <.001).
“Each 10 kg higher mean weight was associated with a lower risk of subsequent hip fracture overall (HR 0.81; CI, 0.70-0.94) and among women (HR 0.76; CI, 0.64-0.91) and with higher BMD (p <.001).”
Total abdominal muscle area is linked with higher bone mineral density in postmenopausal women (p < 0.05).
“Participants in the highest TAMA quartile exhibited significantly higher BMD in both the lumbar spine and hip than those in the lowest quartile (p < 0.05).”
BMI increases bone mineral density in humans (multiple linear regression analysis) (β = 0.18, P = 0.012).
“BMI was positively correlated with the degree of BMD improvement (β = 0.18, P = 0.012), indicating that the higher the BMI, the greater the degree of BMD improvement.”
Human trialmultiple linear regression analysis6-monthfemalesn = 70
Estradiol mediates bone mineral density in humans (-1.15 mg/cm2, 95% CI: -2.54, -0.21).
“In women, an ILI-associated decrease in estradiol of 14% from baseline to year 1 mediated a decline in whole-body BMD (-1.15 mg/cm2, 95% CI: -2.54, -0.21).”
The Journal of clinical endocrinology and metabolism·
Bone mineral density is linked with a lower risk of bone fracture in humans (CKD patients on dialysis (RRT)) (SHR 0.54, 95% CI 0.38-0.75).
“each one-unit increase in BMD T-score was associated with an approximately 45% lower fracture risk in both groups (RRT: SHR 0.54, 95% CI 0.38-0.75; non-RRT: SHR 0.57, 95% CI 0.41-0.79).”
HumansCKD patients on dialysis (RRT)median follow-up of 1,694 daysn = 514
Bone mineral density is linked with a lower risk of bone fracture in humans (HR 0.12, 95% CI 0.05-0.29).
“Higher NN BMD (HR:0.12, 95% CI:0.05-0.29), cross-sectional area (CSA) (0.37, 0.26-0.52), cross-sectional moment of inertia (CSMI) (0.66, 0.50-0.89), section modulus (SM) (0.40, 0.24-0.68) and cortical thickness (CT) (0.00, 0.00-0.01 due to rounding) were associated with decreased risk.”
Bone mineral density is linked with a lower risk of mortality in humans (total femur BMD < 0.682 g/cm2) (HR 0.61, 95% CI 0.53-0.69).
“Below this threshold, each 0.1 g/cm2 increase in BMD was associated with a 39% decrease in all-cause mortality risk (HR = 0.61, 95% confidence interval: 0.53-0.69, P < .0001).”
Bone mineral density is linked with a lower risk of mortality in humans (-0.056, P<0.0001).
“The total effect was strongest for total femur BMD (-0.056, P<0.0001), followed by intertrochanter (-0.061, P<0.0001), trochanter (-0.043, P<0.0001), and femoral neck (-0.025, P=0.002).”
Bone mineral density is associated with mortality in humans (hip fracture).
“Only 5.6% of patients had a BMD test within the first year after the fracture, which was associated with improved treatment adherence and lower mortality.”
Humanship fracturewithin the first year after the fracturen = 552
Bone mineral density predicts mortality in humans (TAVR-scheduled patients) (p = 0.046).
“Lower BMD in patients assessed using non-enhanced CT scans was significantly associated with reduced survival, even after adjusting for predictors of osteoporosis (p = 0.046).”
HumansTAVR-scheduled patientsmedian follow-up period of 837 daysn = 725
Bone mineral density is linked with a lower risk of sarcopenia in humans (adjusted for confounders) (OR 0.30, 95% CI 0.14-0.68).
“femoral neck BMD (odds ratio 0.30, 95% confidence interval 0.14-0.68) were associated with the presence of sarcopenia after adjustment for confounders.”
Hounsfield unit is associated with bone mineral density in humans (r = 0.830 to 0.905, p < 0.05).
“HU values of the sacral vertebrae across all planes were strongly correlated with both sacral spine BMD and the mean BMD values for L1-L2 (r = 0.830 to 0.905, p < 0.05).”
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·
Hounsfield unit is associated with bone mineral density in humans (R2 = 0.88).
“There was a strong correlation between HU values and BMD (R2 = 0.88) as well as T‐score (R2 = 0.89).”
Lean mass is associated with bone mineral density in humans (independent of group).
“Independent of group, total lean mass and body weight positively associated with total, arm, leg bone mineral density and total bone mineral content (all p<0.05).”
Bone mineral density is associated with vertebral fracture in humans (patients with early breast cancer receiving aromatase inhibitors) (HR 0.79, 95% CI 0.66-0.94).
“Higher ALMI (HR, 0.38; 95% CI, 0.22-0.65; P < .001) and BMD (HR, 0.79; 95% CI, 0.66-0.94; P = .01) were associated with lower risk of VF progression.”
Humanspatients with early breast cancer receiving aromatase inhibitorsvertebraup to 30 monthsfemalesn = 769
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·
Skeletal muscle mass is associated with bone mineral density in humans.
“skeletal muscle mass (SMM), skeletal muscle index (SMI), and fat free mass (FFM) were significantly positively correlated with BMD at all sites in both males and females (P < 0.05)”
Skeletal muscle mass is associated with bone mineral density in humans.
“Regardless of BMI group, skeletal muscle mass (SMM), skeletal muscle index and fat-free body mass (FFM) of male and female were significantly positively correlated with BMD of all parts (P < 0.05).”
Exercise is associated with bone mineral density in humans (patients with femoral shaft fractures, with and without HIV).
“By week 12, the intervention group showed higher BMD at the right toe, right thumb and greater trochanter but decreased at fracture sites.”
Human trialpatients with femoral shaft fractures, with and without HIVindividualized home-based exercise programright toe, right thumb, greater trochanter and fracture sites12 weeks post-surgery63.6% malesn = 22
Upright time is associated with bone mineral density in humans during weight loss in older adults with obesity or overweight (p = 0.023 for interaction).
“upright time was positively associated with baseline-adjusted change in aBMD in WL+VEST”
Human trialduring weight loss in older adults with obesity or overweight1 yearn = 131
Calf circumference predicts bone mineral density in humans (postmenopausal osteoporotic women receiving denosumab) (β = 1.76, SE = 0.82, p = 0.03).
“the CC (β = 1.76, SE = 0.82, p = 0.03) and the baseline femoral BMD (β = - 94.19, SE = 26.09, p = 0.0009) were independently associated with femoral BMD gain over time.”
Human trialpostmenopausal osteoporotic women receiving denosumab43 monthsfemalesn = 130
Isobutyric acid is associated with bone mineral density in humans (r = 0.3465).
“Six-month changes in caproic and isobutyric acids showed weak correlations with changes in whole-body BMD (r = 0.3519, p < 0.05 and r = 0.3465, p < 0.05, respectively).”
National Institute of Arthritis and Musculoskeletal and Skin Diseases$4.4MJapan Society for the Promotion of Science¥44.9MFood and Drug Administration$865K
Human observational studies link older age with lower bone mineral density. Human trials report increases with denosumab in Chinese patients with osteoporosis and with resistance training, but no clear effect after eight weeks of aerobic dance in women. Naringenin increases bone mineral density in aging mice.
Summary rewritten as its findings changed.
As it read before
Lower bone mineral density is linked with older age in human observational studies; density is also associated with menopause and muscle mass. Human trials report increases with denosumab in postmenopausal osteoporosis, and a resistance-training trial reports increases. Separate trials show no clear effect from aerobic dance or whole-body vibration.
Lower bone mineral density is linked with older age in human cohorts. Human trials report increases with denosumab in osteoporosis patients, including postmenopausal women at high fracture risk. A trial reports an increase with resistance training, whereas trials of aerobic dance and whole-body vibration in women show no clear effect.
Summary rewritten as its findings changed.
As it read before
Human trials report increased bone mineral density with denosumab in postmenopausal osteoporosis and with resistance training. Trials of aerobic dance and whole-body vibration show no clear effect in women. Human observational studies link lower density with older age and, in postmenopausal women, greater lumbar marrow fat.
Human observational studies link older age with lower bone mineral density. Human trials report increases with denosumab in postmenopausal osteoporosis at high fracture risk and with resistance or virtual reality training, but no clear effect from creatine over two years in women or aerobic dance over eight weeks in women.
Loneliness was linked to higher fracture odds in men, with an odds ratio of 2.46, but not women, in a prospective cohort of 2,850 adults.Loneliness was linked to higher fracture odds in men, with an odds ratio of 2.46, but not women, in a prospective cohort of 2,850 adults.
The model scored 0.843 versus 0.779 for a standard tool on a measure of how well it ranked patients’ fracture risk.The model scored 0.843 versus 0.779 for a standard tool on a measure of how well it ranked patients’ fracture risk.